Priya Raghunathan

VP, Market Access at Former Novartis

Fifteen years in pharma market access across the US and EU5, most recently leading payer strategy for two oncology launches. I advise investors on formulary dynamics, gross-to-net erosion, and how IRA negotiation is reshaping small-molecule pricing. I take roughly six calls a month and specialize in diligence on specialty pharma assets.

Expert networks: GLG, AlphaSights, Guidepoint